A Study of TQB2450 Combined With Anlotinib in Subjects With Ovarian Cancer
Condition: Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Interventions: Drug: TQB2450; Drug: Anlotinib Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Fallopian Tube Cancer | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Study